Therapeutic effects of rifampin and erythromycin in experimental murine brucellosis
- 1 February 2000
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (2) , 111-114
- https://doi.org/10.1046/j.1469-0691.2000.00016-4.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Comparative activity of azithromycin and doxycycline against Brucella spp. infection in miceJournal of Antimicrobial Chemotherapy, 1995
- Therapeutic Effects of Roxithromycin and Azithromycin in Experimental Murine BrucellosisChemotherapy, 1994
- In vitro activities of new macrolides and rifapentine against Brucella sppAntimicrobial Agents and Chemotherapy, 1993
- Comparative in vitro activity of clarithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampinAntimicrobial Agents and Chemotherapy, 1992
- Modern Chemotherapy for Brucellosis in HumansClinical Infectious Diseases, 1990
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Antimicrobial susceptibility of clinical isolates of BrucellaDiagnostic Microbiology and Infectious Disease, 1986
- Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (First of Two Parts)Mayo Clinic Proceedings, 1985